Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
444.6 INR | +1.02% | +1.62% | +3.36% |
05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
04-25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.36% | 2.88B | |
+34.22% | 693B | |
+29.39% | 584B | |
-2.70% | 372B | |
+20.60% | 332B | |
+6.72% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.07% | 168B |
- Stock Market
- Equities
- LAURUSLABS Stock
- News Laurus Labs Limited
- Laurus Labs Pays First Tranche to Acquire Additional Stake in Cell and Gene Therapy Company